D
BioRestorative Therapies, Inc. BRTX
$1.73 -$0.0745-4.14%
Recommendation
Sell
Prev Close
$1.80
Volume
39,279
Avg Vol (90D)
292,754
Market Cap
$13.51M
Dividend & Yield
--
52-Week Range
$1.03 - $2.55
P/E (TTM)
--
EPS (TTM)
-$1.17
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
BioRestorative Therapies Reports Strong Growth Amid Challenges
3/29/2025 - TipRanks Financial Blog
BioRestorative Therapies Reports Financial Gains and Clinical Progress
3/28/2025 - TipRanks Financial Blog
BioRestorative Therapies, Inc. (BRTX) Q4 2024 Earnings Call Transcript
3/28/2025 - SeekingAlpha
BioRestorative Therapies, Inc. (BRTX) Q4 2024 Earnings Call Transcript
3/28/2025 - Seeking Alpha: Transcripts
BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update
3/27/2025 - GuruFocus
BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update
3/27/2025 - Globe Newswire
BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025
3/20/2025 - GuruFocus
BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025
3/20/2025 - Globe Newswire
BioRestorative Therapies (OTCMKTS:BRTXQ) Stock Price Up 0.3% - Here's What Happened
3/15/2025 - MarketBeat
Analysts Are Bullish on Top Healthcare Stocks: BioRestorative Therapies (BRTX), Rocket Pharmaceuticals (RCKT)
3/1/2025 - TipRanks Financial Blog
BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
2/27/2025 - Globe Newswire
BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update
2/27/2025 - Globe Newswire
BioRestorative Therapies to provide clinical pipeline update on February 27
2/25/2025 - The Fly
BioRestorative to Provide a Positive FDA Update on Clinical Pipeline
2/25/2025 - Globe Newswire
Head-To-Head Analysis: BioRestorative Therapies (NASDAQ:BRTX) & Quipt Home Medical (NASDAQ:QIPT)
2/25/2025 - Ticker Report
BioRestorative Therapies- BRTX-100 program receives FDA Fast Track designation
2/20/2025 - The Fly
BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program
2/20/2025 - Globe Newswire
BioRestorative Therapies (OTCMKTS:BRTXQ) Stock Price Down 12.9% - Should You Sell?
2/20/2025 - MarketBeat
Short Interest in BioRestorative Therapies, Inc. (NASDAQ:BRTX) Increases By 81.0%
2/15/2025 - Ticker Report
BioRestorative Therapies Issues Regulation FD Disclosure
2/10/2025 - TipRanks Financial Blog
BioRestorative Therapies announces new data on BRTX-100 presented at ORS 2025
2/10/2025 - TipRanks Financial Blog
BioRestorative Therapies announces new data on BRTX-100 presented at ORS 2025
2/10/2025 - The Fly
BRTX-100 Front and Center at ORS 2025
2/10/2025 - Globe Newswire
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Down 0.9% - Here's Why
1/29/2025 - MarketBeat
With BioRestorative Therapies Up 18%, Insider Buyers Count Their Returns
1/17/2025 - Simply Wall St
Income Statement
Total Revenue (TTM)
$401.00K
EBITDA (TTM)
-$11.37M
EBIT (TTM)
-$11.56M
Net Income (TTM)
-$8.98M
Balance Sheet
Total Assets (Q)
$12.28M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$3.75M
Book Value Per Share (Q)
$1.23
Cash Flow
Cash from Operations (TTM)
-$8.23M
Cash from Investing (TTM)
$514.60K
Cash from Financing (TTM)
$7.38M
Net Change in Cash (TTM)
-$336.50K
Filings
Filing Date
Friday, March 28, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Jun 9 and 13 (est)
Price History
Loading...
Beta
1.33
7-Day Total Return
-1.96%
30-Day Total Return
-4.14%
60-Day Total Return
-4.14%
90-Day Total Return
19.41%
Year to Date Total Return
15.81%
1-Year Total Return
28.77%
2-Year Total Return
-51.26%
3-Year Total Return
-68.63%
5-Year Total Return
115.69%
52-week Low
Jun 10, 2024 - $1.03
52-week High
Jan 29, 2025 - $2.55
Valuation
Market Cap
$13.51M - Nano Cap
Enterprise Value
$2.79M
Price/Sales (TTM)
36.51
Price/Book (Q)
1.46
Dividends and Shares
Shares Outstanding
8.13M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.biorestorative.com
Phone Number
631 760 8100
Address
40 Marcus Drive
Melville, NY 11747
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs relate to... more
NASDAQ 04/04/2025 12:01PM Eastern Quotes delayed
Weiss Ratings